Resources | NITAG RESOURCE CENTER

2014 ∙ Fortanier, A. C. Venekamp, R. P. Boonacker, C. W. Hak, E. Schilder, A. G. Sanders, E. A. Damoiseaux, R. A.

Pneumococcal conjugate vaccines for preventing otitis media

2014 ∙ Deloria Knoll, M. Park, D. E. Johnson, T. S. Chandir, S. Nonyane, B. A. Conklin, L. Fleming-Dutra, K. E. Loo, J. D. Goldblatt, D. Whitney, C. G. O'Brien, K. L.

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity

2014 ∙ Loo, J. D. Conklin, L. Fleming-Dutra, K. E. Deloria Knoll, M. Park, D. E. Kirk, J. Goldblatt, D. O'Brien, K. L. Whitney, C. G.

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia

2014 ∙ Conklin, L. Loo, J. D. Kirk, J. Fleming-Dutra, K. E. Deloria Knoll, M. Park, D. E. Goldblatt, D. O'Brien, K. L. Whitney, C. G.

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children

2014 ∙ Fleming-Dutra, K. E. Conklin, L. Loo, J. D. Knoll, M. D. Park, D. E. Kirk, J. Goldblatt, D. Whitney, C. G. O'Brien, K. L.

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage

2014 ∙ Sudarsanam, T. D. Tharyan, P.

Vaccines for preventing pneumococcal infection in adults. Summary of the evidence and implications for public health programmes

2014 ∙ ACIP

ACIP minutes meeting

2014 ∙ Conseil Supérieur de la Santé (CSS)

Pneumococcal Vaccine

2014 ∙ CFV

recommanda- tions visant à prévenir les maladies invasives à pneumocoques chez les groupes à risque

2014 ∙ NACI

Update on the Use of Pneumococcal Vaccines: Addition of Asthma as a High-Risk Condition